Obigen Pharma Inc. (TPEX:7876)
Taiwan · Delayed Price · Currency is TWD 37.10
+0.60 (1.64%)
At close: May 29, 2026
Obigen Pharma Market Cap
Obigen Pharma has a market cap or net worth of 3.97 billion as of May 29, 2026.
Market Cap
3.97B
Enterprise Value
3.53B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
37.10
Market Cap Chart
Since November 24, 2025, Obigen Pharma's market cap has decreased from 4.62B to 3.97B, a decrease of -14.12%. That is a compound annual growth rate of -25.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.97B | -4.87% |
| Dec 31, 2025 | 4.17B | -9.72% |
| Nov 24, 2025 | 4.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 18.98B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.17B |
| Uwell Biopharma | 8.03B |
| Intelligene | 6.67B |
| Pet Pharm Biotech | 3.08B |
| BIONET Therapeutics | 2.72B |
| FullHope Biomedical | 1.25B |
| Genomics BioSci & Tech. | 1.22B |